Autres langues Amicogen, Inc.

Actions

A092040

KR7092040005

Recherche biotechnologique et médicale

Cours en clôture Korea S.E. 02/10/2026			Varia. 5j.	Varia. 1 janv.
988,00 ^KRW	-0,20%		+5,67%	-44,56%

14/08	Amicogen, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
14/05	Amicogen, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

21/09	Amicogen, Inc.(KOSDAQ:A092040) dropped from S&P Global BMI Index
14/08	Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
04/08	Amicogen, Inc. cancelled the transaction announced on June 22, 2026
22/06	Amicogen, Inc. announced that it expects to receive KRW 9.9999989 billion in funding
14/05	Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
23/03	Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
14/11	Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
22/09/25	Amicogen, Inc.(KOSDAQ:A092040) added to S&P Global BMI Index
20/08/25	Bio-Works Launches WorkBeads AffimAb Edge: Strategic Expansion in the Protein A Resin Market
14/08/25	Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
11/08/25	Amicogen, Inc. announced that it has received KRW 7 billion in funding from BIFIDO Co., Ltd.
14/05/25	Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
25/04/25	Amicogen, Inc.(KOSDAQ:A092040) dropped from S&P Global BMI Index
19/03/25	Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
10/12/24	An undisclosed buyer agreed to acquire an unknown stake in Amicogen Biopharm Co., Ltd. from Amicogen, Inc. for KRW 54.7 billion.
21/11/24	Enzynomics Co., Ltd. completed the acquisition of 37.32% stake in SKINMED Co., Ltd. from Amicogen, Inc..
14/11/24	Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
13/09/24	Whan In Pharm Co.,Ltd. completed the acquisition of 30% stake in BIFIDO Co., Ltd. from Amicogen, Inc..
13/09/24	An undisclosed buyer completed the acquisition of 30% stake in BIFIDO Co., Ltd. from Amicogen, Inc..
30/08/24	Whan In Pharm Co.,Ltd. agreed to acquire 30% stake in BIFIDO Co., Ltd. from Amicogen, Inc. for KRW 15 billion.
30/08/24	An undisclosed buyer agreed to acquire 30% stake in BIFIDO Co., Ltd. from Amicogen, Inc. for KRW 15.4 billion.
14/08/24	Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
19/07/24	Amicogen, Inc. announced that it has received KRW 40 billion in funding
18/07/24	Amicogen, Inc. announced that it has received KRW 13 billion in funding
16/07/24	Amicogen, Inc. announced that it expects to receive KRW 13 billion in funding